Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma.
Liang C, Li F, Wang L, Zhang ZK, Wang C, He B, Li J, Chen Z, Shaikh AB, Liu J, Wu X, Peng S, Dang L, Guo B, He X, Au DWT, Lu C, Zhu H, Zhang BT, Lu A, Zhang G.
Liang C, et al. Among authors: wang l, wang c.
Biomaterials. 2017 Dec;147:68-85. doi: 10.1016/j.biomaterials.2017.09.015. Epub 2017 Sep 13.
Biomaterials. 2017.
PMID: 28938163